We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Regulates Insulin to Extend Lifespan

By Biotechdaily staff writers
Posted on 05 Sep 2005
Scientists have found a protein that has demonstrated the ability to extend life in laboratory mice by regulating insulin. More...
The protein, called Klotho, is found in various species. In mice, it performs like a hormone circulating through the bloodstream and attaches to cells.

Treatments based on this hormone may provide a means to extend the life span of living organisms or lessen the effects of aging, according to Dr. Makoto Kuro-o, assistant professor of pathology at the University of Texas Southwestern Medical Center (Dallas, TX, USA) and senior author of the study, which was published in the August 25, 2005, online edition of the journal Science. "It could be one of the significant steps for developing anti-aging therapy,” noted Dr. Kuro-o.

Dr. Kuro-o and coworkers initially discovered the Klotho gene in 1997, naming it after one of the mythical Greek fates who controlled the length of human life. Their earlier studies demonstrated that mutant mice lacking the Klotho gene appear healthy until approximately three to four weeks old, when they begin to show signs of aging, developing osteoporosis, skin atrophy, arteriosclerosis, and emphysema. The mice died prematurely at about two months.

For the current study, the investigators created a second strain of mutant mice in which the Klotho gene produced more of the protein than in normal mice. Those mice lived between 19-31% longer than normal mice. The scientists were particularly interested in how the hormone affected insulin, because making an animal resistant to insulin increases its lifespan--a phenomenon found in animals ranging from worms to mice.

The mice with higher levels of Klotho had more insulin in their system than the healthy mice, indicating that the Klotho mice were resistant to insulin; they had to generate it to make up for the resistance. The contrary was true with the mice lacking Klotho. They were more sensitive to insulin and had decreased levels of it.

The influence on insulin creates an obstacle for Klotho should it be used as an anti-aging therapy. It may lengthen life spans, but it could also make an animal diabetic. Mice with the excessive Klotho also had less offspring than normal mice, according to Dr. Kuro-o.




Related Links:
University of Texas Southwestern Medical Center

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.